Taken together, targeting of SRC activity by dasatinib or siRNA enhanced gemcitabine-induced cell death by inducting apoptotic cell death and reducing the level of ALDH1A1 expression in ALDH1A1-enriched pancreatic cancer MIA PaCa-2 cells. Here, ALDH1A1 is linked to pancreatic neoplasm.